Progressive Corp/Oh/
$208.31B- Market cap
- $125.73B
- Debt
- +$92.72B
- Cash
- −$10.13B
Capital structure 58% equity / 42% debt · EV / Revenue 2.38x · EV / EBITDA 14.06x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: PGR stock price vs HIMS: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at HIMS's multiple
Needs HIMS P/E.
Implied fair value · at PGR's multiple
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: PGR FY 2025 (ended Dec 31, 2025) · HIMS FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 58% equity / 42% debt · EV / Revenue 2.38x · EV / EBITDA 14.06x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
PROGRESSIVE CORP/OH/ · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
HIMS & HERS HEALTH, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
3.06x
2.48x
Net debt / EBITDA
Leverage against operating earnings
5.58x
7.55x
Cash and equivalents
Liquid reserves on the balance sheet
$10.13B
$228.62M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ALLSTATE CORP
PGR vs ALL
TRAVELERS COMPANIES, INC.
PGR vs TRV
Chubb Ltd
PGR vs CB
HARTFORD FINANCIAL SERVICES GROUP, INC.
PGR vs HIG
American International Group, Inc.
PGR vs AIG
MARKEL GROUP INC.
PGR vs MKL
Teladoc Health, Inc.
PGR vs TDOC
GoodRx Holdings, Inc.
PGR vs GDRX
CLOVER HEALTH INVESTMENTS, CORP. /DE
PGR vs CLOV
Roivant Sciences Ltd.
PGR vs ROIV
$92.72B
$1.34B
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.